Mentions: Patented Medicines Prices Review Board
Pharma companies urge Ottawa to postpone changes to lower drug prices to next year    May 20, 2020

Debbie Lawes
Pharmaceutical R&D spending remains far below industry’s 10% commitment – PMPRB report    December 13, 2017

Mark Henderson
Generic drug report attacks brand-name industry    November 11, 2013

Guest Contributor











Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.